Taylor Paul J, Cooper Donald P, Gordon Richard D, Stowasser Michael
Endocrine Hypertension Research Centre, University of Queensland, Greenslopes Hospital, Brisbane, Australia.
Clin Chem. 2009 Jun;55(6):1155-62. doi: 10.1373/clinchem.2008.116004. Epub 2009 Apr 9.
Reliable measurement of aldosterone with less interlaboratory variation than RIA would help standardize testing for primary aldosteronism. We set out to validate a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for aldosterone in human plasma.
We prepared samples (EDTA plasma, lithium heparin plasma, and serum from separator and plain clot tubes) and measured aldosterone using online HPLC-MS/MS with d(7)-aldosterone as internal standard. We also analyzed EDTA plasma samples by immunoassay. We established a reference range for HPLC-MS/MS aldosterone by analyzing blood collected midmorning from 97 normotensive seated subjects.
The linear range was 69.4-5548.0 pmol/L (2.5-200 ng/dL) (r(2) > 0.994, n = 14). Inter- and intraday analytical recovery and imprecision for quality control samples of 166.4, 1109.6, and 4161.0 pmol/L (6.0, 40.0, and 150.0 ng/dL) were 92.2%-102.0% and <6.3%, respectively (n = 5). The lower limit of quantification was 69.4 pmol/L (2.5 ng/dL), with inter- and intraday analytical recovery and imprecision of 91.4%-94.5% and <9.5% (n = 5). No interferences were observed in plasma from Addison's disease patients (n = 5). Comparison of collection tubes, using EDTA as the reference, revealed similar aldosterone results. Comparison of HPLC-MS/MS with immunoassay gave an acceptable mean bias (0.83%) but wide range (-44.8% to 39.7%) of differences. HPLC-MS/MS aldosterone concentrations in normotensive subjects ranged from <69.4 to 635.2 pmol/L (<2.5 to 22.9 ng/dL).
This first reported aldosterone method using online HPLC-MS/MS is precise across the clinically relevant range, not influenced by collection tube type, and offers semiautomated sample preparation and high throughput.
与放射免疫分析(RIA)相比,能更可靠地测量醛固酮且实验室间差异更小的方法,将有助于原发性醛固酮增多症检测的标准化。我们着手验证一种用于检测人血浆中醛固酮的高效液相色谱 - 串联质谱法(HPLC-MS/MS)。
我们制备了样本(乙二胺四乙酸(EDTA)血浆、肝素锂血浆以及来自分离胶管和平板凝血管的血清),并使用以d(7)-醛固酮为内标的在线HPLC-MS/MS测量醛固酮。我们还通过免疫分析法分析了EDTA血浆样本。通过分析97名血压正常的坐位受试者上午采集的血液,建立了HPLC-MS/MS法检测醛固酮的参考范围。
线性范围为69.4 - 5548.0 pmol/L(2.5 - 200 ng/dL)(r(2) > 0.994,n = 14)。166.4、1109.6和4161.0 pmol/L(6.0、40.0和150.0 ng/dL)质量控制样本的日间和日内分析回收率及不精密度分别为92.2% - 102.0%和<6.3%(n = 5)。定量下限为69.4 pmol/L(2.5 ng/dL),日间和日内分析回收率及不精密度分别为91.4% - 94.5%和<9.5%(n = 5)。在艾迪生病患者的血浆中未观察到干扰(n = 5)。以EDTA为参照比较不同采血管,结果显示醛固酮含量相似。HPLC-MS/MS法与免疫分析法比较,平均偏差可接受(0.83%),但差异范围较宽(-44.8%至39.